Tenaya Therapeutics Aktie
WKN DE: A3CWF0 / ISIN: US87990A1060
|
29.06.2026 14:56:41
|
Tenaya Therapeutics Appoints Eric Hyllengren As CFO
(RTTNews) - Tenaya Therapeutics, Inc. (TNYA), a clinical-stage biotechnology company, said on Monday that it has appointed Eric Hyllengren as Chief Financial Officer with effect from July 13.
Hyllengren most recently served as CFO of Zura Bio. Prior to Zura Bio, he served as CFO and Chief Operating Officer of Atara Biotherapeutics.
Earlier, he held roles of increasing responsibility across finance, investor relations, and business development over the course of 15 years at Amgen.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Tenaya Therapeutics Inc Registered Shs
| Keine Nachrichten verfügbar. |
Analysen zu Tenaya Therapeutics Inc Registered Shs
Aktien in diesem Artikel
| Tenaya Therapeutics Inc Registered Shs | 0,73 | 2,43% |
|